Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that effective as of September 11, 2024, its board of directors authorized ...

Inc. Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary ...

A unique feature of airway clearance methods using ventilatory support is the potential to enhance lung volumes and expiratory flow rates during circumstances where the respiratory system is ...

Electromed shares rose after the medical-equipment maker posted quarterly earnings ahead of market expectations. Shares of the maker of airway-clearance devices rose 7.2% to $17.21 in after-hours ...

Q4 2024 Earnings Call Transcript August 27, 2024 Electromed, Inc. beats earnings expectations. Reported EPS is $0.2, ...

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. It offers smartvest, and airways clearance system to patients with compromised pulmonary function.

We sell to a limited number of home medical equipment distributors, who in turn sell our SmartVest System in the U.S ... the Investor Relations section of Electromed’s website and directly ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

NEW PRAGUE, Minn., August 27, 2024 -- ( BUSINESS WIRE )--Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results ...

Greetings, and welcome to the Electromed Fourth Quarter 2024 Earnings ... The release is currently available on the Company's website at www.smartvest.com. Before we get started, I’d like ...